Navigation Links
Telomerase Presentations at the AACR 2007 Annual Meeting

>

Cancer Stem Cells

Cancer stem cells (CSCs) are a rare sub-population of self-renewing, immortal tumor cells capable of differentiating into the various types of cells seen within the bulk tumor. They are now widely believed to be distinct from the bulk tumor cells and to be responsible for many cases of drug resistance and cancer recurrence. The 2007 AACR meeting had a dramatic increase in CSC presentations, and there is a growing awareness that effective cancer treatment will require drugs that kill CSCs.

At previous cancer meetings, Drs. W. Matsui and R. Jones of Johns Hopkins University reported on telomerase activity in myeloma stem cells. The Johns Hopkins team demonstrated that Geron's telomerase inhibitor, GRN163L, blocked growth and colony formation in both the stem and differentiated subpopulations of myeloma cells. In these studies, no other compounds have been shown to be as active against myeloma CSCs. Geron is currently planning a trial with GRN163L in myeloma patients.

Other Telomerase and Telomere Presentations

Other studies presented at the AACR meeting focused on the degree of telomere loss prior to telomerase activation in various tumor types, the role of telomere dysfunction in tumorigenesis, and use of the telomerase promoter to drive tumor cell death.

"The data presented at AACR contribute to the growing body of evidence regarding the importance of telomerase targeted therapies for the treatment of cancer," noted Alan Colowick, M.D., M.P.H., Geron's president, oncology. "Geron currently has two clinical studies of GRN163L underway in patients with chronic lymphocytic leukemia (CLL) and solid tumor malignancies. We plan to initiate two additional studies of GRN163L in patients with multiple myeloma and non-small cell lung cancer, as well as a study of GRNVAC1 in patients with acute myelogenous leukemia (AML), in the months ahead.

Geron is developing first-in-class biopharmaceuticals for the treatment
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
2. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. Inspire Announces Presentations at Two European Scientific Conferences
8. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
9. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
10. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
11. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Telomerase Presentations the AACR Annual Meeting
(Date:10/17/2014)... , Oct. 17, 2014 Research ... "Research and Development Prospect of China Dialysis ... Based on the 2013 version, this ... policies about dialysis industry and the relevant effect ... about dialysis industry segmentations. Moreover, it analyzes Chinese ...
(Date:10/17/2014)... , Oct. 17, 2014 The ... Medical Technology Policy: The Green Park ... FDA, public and private payers, medical device and ... and other experts January 12, 2015 at its ... value of weight loss treatments.  Participants will discuss ...
(Date:10/17/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" ... biopharmaceutical company in China , ... from the China Food and Drug Administration (the ... concentrate ("PCC") at its Shandong Taibang facility. The ... facility for Good Manufacturing Practices ("GMP") compliance in ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... Network, Inc. (Other OTC: CNWI.PK) (the "Company") today announced that ... "Reverse Stock Split"). The Reverse Stock Split will take effect ... 2011 (the "Effective Date"). On the Effective Date, the Company,s ... approximately 20 business days, after which it will revert to ...
... SAN FRANCISCO, Calif., May 5, 2011 Rigel Pharmaceuticals, Inc. ... the company,s chief financial officer, is scheduled to present a ... Care Conference in Las Vegas on Tuesday, May 10th at ... The presentation will be webcast live and can ...
Cached Medicine Technology:Cardiac Network Announces Reverse Stock Split 2
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... Houston, Texas (PRWEB) October 20, 2014 ... invited to present the key elements of his innovative ... visiting professor to plastic surgery residents and faculty at ... (UTMB) , where he, too, was once a medical ... of the largest private cosmetic plastic surgery practices in ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 The ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the ... excellent platforms for those who want to buy ... same time. , The IT manager of Top10BestSEOHosting.com ... the most recommended suppliers for everyone. A lot ...
(Date:10/19/2014)... Texas (PRWEB) October 20, 2014 ... development for Partial Seizure, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Partial Seizure and special features on late-stage and ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many ... latest designs of 2014 mother of the bride ... are offered with big discounts, up to 70% off. ... can enjoy this special offer. , Owing to ... become one of the leading brands in the global ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
... site in a mouse brain well connected to other ... entire brainafter one injection of gene therapy. If these ... may have a potential method for gene therapy to ... neurological disorders, such as Tay-Sachs disease. , Researchers from ...
... to Health Coverage Expected to Increase for Small Business Owners ... http://www.bluecrossca.com/click4biz ... business sector,is one of the fastest growing segments of California,s ... provide their,employees with health insurance. Blue Cross of California has ...
... in antioxidant vitamins and minerals does not seem to prevent ... finds a study published on bmj.com today. , ... loss in older people. It is caused by the progressive ... in the centre of the retina at the back of ...
... MONICA, Calif., Oct. 8 Proposed,regulations that would ... stem cell research grants to for-profit organizations fail,to ... for California taxpayers,paying for the research, the Foundation ... "To ensure that the people who have paid ...
... fitness,and healthy living in communities across the USA, is ... held in conjunction with the 30th,anniversary of the Detroit ... Expo, which runs Oct. 19-20 at Cobo,Center, exemplifies that ... that provide services to runners. The Detroit Free ...
... Veterinary Medical Association awarded its 2007 Student/Recent,Graduate Award, ... in Lacey. (Logo: http://www.newscom.com/cgi-bin/prnh/20070613/WSVMALOGO ), ... of his dedication to,organized veterinary medicine in Washington. ... Veterinary Medicine, he has served as a,member of ...
Cached Medicine News:Health News:One shot of gene therapy spreads through brain in animal study 2Health News:One shot of gene therapy spreads through brain in animal study 3Health News:New Online Tool Makes Enrollment in Blue Cross of California Easier 2Health News:Antioxidants do not prevent degenerative eye disease 2Health News:Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn 2Health News:Saturn Shows Its Commitment to Health and Fitness by Becoming Expo Title Sponsor for The Detroit Free Press/Flagstar Marathon 2Health News:Lacey Veterinarian Awarded 2007 WSVMA Recent Graduate Award 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: